The effects of fibrin-icariin nanoparticle loaded in poly (lactic-co-glycolic) acid scaffold as a localized delivery system on chondrogenesis of human adipose-derived stem cells

被引:8
作者
Gorji, Mona [1 ]
Ghasemi, Nazem [1 ]
Setayeshmehr, Mohsen [2 ]
Zargar, Anooshe [2 ]
Kazemi, Mohammad [3 ]
Soleimani, Mitra [1 ]
Hashemibeni, Batool [1 ]
机构
[1] Isfahan Univ Med Sci, Fac Med, Dept Anat Sci & Mol Biol, Esfahan, Iran
[2] Isfahan Univ Med Sci, Biomat Nanaotechnol & Tissue Engn Grp, Dept Adv Med Technol, Esfahan, Iran
[3] Isfahan Univ Med Sci, Sch Med, Dept Genet & Mol Biol, Esfahan, Iran
关键词
Adipose-derived stem cells; chondrogenesis; fibrin nanoparticles; icariin; poly (lactic-co-glycolic) acid; IN-VIVO; CARTILAGE; CHONDROCYTES; MATRIX; PLGA; DIFFERENTIATION; TRANSDUCTION; INHIBITOR; BMP-2;
D O I
10.4103/abr.abr_143_19
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Nowadays, cartilage tissue engineering is the best candidate for regeneration of cartilage defects. This study evaluates the effect of fibrin/icariin (ICA) nanoparticles (F/I NPs) on chondrogenesis of stem cells. Materials and Methods: F/I NPs were characterized by Dynamic Light Scattering DLS. Poly (lactic-co-glycolic) acid (PLGA)-F/I NP scaffold was fabricated and assessed by scanning electron microscope. Human adipose-derived stem cells (hADSCs) were seeded on scaffold and induced for chondrogenesis. After 14 days, cell viability and gene expression were analyzed by the 3-(4, 5- dimethylthiazol-2yl)-2, 5-diphenyltetrazolium bromide (MTT) assay. MTT assay and real-time polymerase chain reaction (RT-PCR). Results: The size and surface charge of F/I NP were about 28-30 nm and - 17, respectively. The average of pore size of PLGA and PLGA-fibrin/ICA was 230 and 340 mu m, respectively. Cell viability of differentiated cells in P/F group was higher than others significantly (P <= 0.05). Furthermore, quantitative RT-PCR analysis demonstrated that ICA upregulated cartilaginous-specific gene expression. Furthermore, the results of the expression of type I collagen revealed that ICA downregulated this gene significantly (P < 0.01). Conclusions: The results indicated that F/I NP could be a potential factor for chondrogenesis of stem cells and downregulation of fibrocartilage marker.
引用
收藏
页数:7
相关论文
共 50 条
[1]  
Bahrami Maryam, 2018, Adv Biomed Res, V7, P36, DOI 10.4103/2277-9175.225925
[2]   Controllable surface modification of poly(lactic-co-glycolic acid) (PLGA) by hydrolysis or aminolysis I:: Physical, chemical, and theoretical aspects [J].
Croll, TI ;
O'Connor, AJ ;
Stevens, GW ;
Cooper-White, JJ .
BIOMACROMOLECULES, 2004, 5 (02) :463-473
[3]   The dawning era of polymer therapeutics [J].
Duncan, R .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (05) :347-360
[4]   Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applications [J].
Galvin, Paul ;
Thompson, Damien ;
Ryan, Katie B. ;
McCarthy, Anna ;
Moore, Anne C. ;
Burke, Conor S. ;
Dyson, Maya ;
MacCraith, Brian D. ;
Gun'ko, Yurii K. ;
Byrne, Michelle T. ;
Volkov, Yuri ;
Keely, Chris ;
Keehan, Enda ;
Howe, Michael ;
Duffy, Conor ;
MacLoughlin, Ronan .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2012, 69 (03) :389-404
[5]   Magnetic nanoparticles for cancer therapy [J].
Goya, G. F. ;
Grazu, V. ;
Ibarra, M. R. .
CURRENT NANOSCIENCE, 2008, 4 (01) :1-16
[6]   Chondrocytes seeded onto poly (L/DL-lactide) 80%/20% porous scaffolds: A biochemical evaluation [J].
Grad, S ;
Zhou, L ;
Gogolewski, S ;
Alini, M .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2003, 66A (03) :571-579
[7]  
Hashemibeni B., 2008, INT J BASIC MED SCI, V11, P10
[8]  
Hashemibeni B, 2017, INT J ADV BIOTECHNOL, V8, P595
[9]   Icariin isolated from Epimedium pubescens regulates osteoblasts anabolism through BMP-2, SMAD4, and Cbfa1 expression [J].
Hsieh, Tsai-Pei ;
Sheu, Shiow-Yunn ;
Sun, Jui-Sheng ;
Chen, Ming-Hong ;
Liu, Man-Hai .
PHYTOMEDICINE, 2010, 17 (06) :414-423
[10]   Advances and challenges of nanotechnology-based drug delivery systems [J].
Jiang, Wen ;
Kim, Betty Y. S. ;
Rutka, James T. ;
Chan, Warren C. W. .
EXPERT OPINION ON DRUG DELIVERY, 2007, 4 (06) :621-633